MedTrace Logo

Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance

NCT06773650 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 385

Last updated 2025-01-14

No results posted yet for this study

Summary

Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM).

It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible).

The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.

Conditions

  • Lactose Intolerant
  • Lactose Malabsorption
  • Lactose Intolerance

Interventions

OTHER

Completion of online survey

The online survey aims to reach a representative sample of the Italian population to identify their knowledge regarding LI

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-08
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06773650 on ClinicalTrials.gov